10h15 / 11h00
Organizational track (153)
CONSIDERATION ON THE REVISED BIOETHIC LAW: DIVERSE PERSPECTIVES IN EUROPE
CHAIRMAN : Mariam KLOUCHE, Professor and Physician at Laborzentrum Medizinisches Versorgungszentrum, Bremen – Germany
SPEAKERS
— Stefaan CALLENS, Professor of Health Law, Center for Ethical and Biomedical Laws, Leuven – Belgium
— Mariam KLOUCHE, Professor and Physician at Laborzentrum Medizinisches Versorgungszentrum, Bremen – Germany
— Delphine STOFFEL, Lawyer at the Ministry of Health, Government of the Grand Duchy of Luxembourg – Luxembourg
12h15 / 13h00
Scientific track (153)
STROKE: DIAGNOSIS, CARE AND NEW BIOMARKERS
CHAIRMAN : Bernard GOUGET, President-Healthcare Division Committee COFRAC, Paris – France
SPEAKERS
— Joan MONTANER, Neurovascular Research Laboratory, Barcelona – Spain
15h00 / 15h45
Scientific track (153)
NONINVASIVE ASSESSMENT OF LIVER DISEASE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
CHAIRMAN : Dominique BERNARD, Pharmacist biologist laboratory BIOSUD, Pont du Casse – France
SPEAKERS
— Laurent CASTERA, MD PhD, Hepatology Department at Beaujon Hospital, APHP, INSERM UMR1149, Inflammation Research Center Paris Montmartre, Paris-VII University, Clichy – France
16h30 / 17h15
Scientific track (153)
NEW BIOMARKERS IN RENAL FIBROGENESIS
in partnership with the French-Speaking Society of Nephrology, Dialysis and Transplantation (SFNDT)
CHAIRMAN : Jean-Charles DUGIMONT, Biologist, laboratory BioCentre, Marcq en Baroeul – France
Francis GUINARD, Secretary of SDB, President of URPS region CVL, BioExcel, Bourges – France
SPEAKERS
Renal fibrogenesis: from molecular mecanisms to urine biomarkers
— Fabiola TERZI, Research Director Team "Mechanisms and Therapeutic Strategies for Chronic Renal Diseases" – Necker Institute, INSERM U1151, Paris University, Necker Hospital, Paris – France
Impact of renal fibrogenesis: Urine analysis as a new biomarker
— Alexandre HERTIG, Professor of Nephrology at Pierre and Marie Curie University, Sorbonne University, Paris – France
17h15 / 18h00
Scientific track (153)
THE FUTURE OF LABORATORY MEDICINE
CHAIRMAN : Bernard GOUGET, President-Healthcare Division Committee COFRAC, Paris – France
SPEAKERS
—
Graham BEASTALL, Past President at International Federation of Clinical Chemistry & Laboratory Medicine (IFCC), Glasgow – Scotland
11h15 / 12h00
Scientific track (151)
ALZHEIMER MARKERS: FROM DIAGNOSIS TO INNOVATION
CHAIRMAN : Francis GUINARD, Secretary of SDB, President of URPS region CVL, BioExcel, Bourges – France
SPEAKERS
— David MEYRONET, Doctor in Anatomy and Pathological Cytology, Hospices Civils, Lyon – France
— Armand PERRET-LIAUDET, Head of the Department of Biochemistry and Molecular Biology, CBPE - GHE, Lyon – France
12h00 / 12h45
Scientific track (153)
VALUE OF NEW BIOLOGICAL MARKERS IN CARDIOLOGY
CHAIRMAN : Bernard GOUGET, President-Healthcare Division Committee COFRAC, Paris – France
SPEAKERS
— Damien GRUSON, PhD, EuSpLM, FESC Head of Department of Medical Biochemistry SaintLuc University Clinics, UCL Brussels, Brussels – Belgium
— Mehdi KHOURSSAJI, Louvain University, Brussels – Belgium
15h00 / 15h45
Scientific track (151)
PREDISPOSITIONS TO BREAST CANCER AND TARGETED THERAPIES
CHAIRMAN : Virginie FERRÉ, Director of the Department of Biological and Pharmaceutical Sciences, University of Nantes, Nantes – France
SPEAKERS
— Dominique STOPPA-LYONNET, Physician, professor of genetics at the University Paris Descartes and head of the genetics department of the Curie Institute, Paris – France
15h45 / 16h30
HEREDITARY DISEASES OF METABOLISM AND CANCER IN THE AGE OF PRECISION MEDICINE
CHAIRMAN : Hervé PUY, University Professor, Head of Biology - Pharmacy - Research, Biophare HUPNVS, CRI-UMR1149 Paris Diderot University, Paris – France
SPEAKERS
— Soumeya BEKRI, Professor of Biochemistry and Molecular Biology, UFR Health, University of Rouen Normandy, Head of Department of Metabolic Biochemistry, University Hospital of Rouen, Rouen – France
17h00 / 17h45
Technical track (151)
APPROVAL OF EUROPEAN ACCREDITATIONS
CHAIRMAN : Bernard GOUGET, President-Healthcare Division Committee COFRAC, Paris – France
SPEAKERS
European perspectives on accreditation dynamics in medical biology, feedback on the EA survey
— Hélène MEHAY, Director of the Human Health Section, CoFrac, Paris – France
International accreditation standard ISO15189 in Europe: zoom on the difficulties of application
— Isabel DE LA VILLA, Head of the Department of Care at ENAC, Spanish Accreditation – Spain
— Jean-Marc GIANNOLI, Medical biologist, Laboratories Dyomédéa-Néolab, President of Labac, standard technical evaluator NF EN ISO 15189, member of the Technical Committee of Accreditation Human Health Section of Cofrac, Technical Expert ISO / TC212, Lyon – France
— Giselle NICK-MÄENPÄA, Finnish Accreditation Service (FINAS) – Finland
— Elke VAN ROSSEN, Head of Accreditation of Medical and Life Sciences Laboratories (BELAC) - Belgium
— Anne VASSAULT, Quality consultant and expert member of ISO 2012, Paris – France
17h15 / 18h00
Atelier partenaire Roche Diagnostics France (Salle 152)
Stratégie d’intégration de paramètres innovants ou spécialisés dans une pratique courante, importance de la collaboration clinico-biologique
Que ce soit l’optimisation de dosages déjà réalisés ou l’intégration de nouveaux marqueurs, le dialogue avec les cliniciens est essentiel dans le choix des solutions et technologies de dosage afin de rendre un service adapté et des résultats conformes aux attentes des prescripteurs. Au-delà de ces aspects, la stratégie d’intégration de nouveaux marqueurs nécessite une phase d’évaluation clinique et biologique. Au travers d’exemples concrets, le CHU de Nantes nous présente sa méthode pour offrir le meilleur compromis entre service médical rendu, qualité, coût et praticabilité.
CHAIRMAN : Nicolas ZEITOUN, Responsable Promotion de la Valeur Médicale – Health Care Development, Roche Diagnostics France, Meylan – France
SPEAKERS
— Pr Damien MASSON, Chef de Service & Directeur de Recherche, CHU de Nantes, Nantes – France
